Targeted deletion of ectonucleoside triphosphate diphosphohydrolase 1/CD39 leads to desensitization of pre- and postsynaptic purinergic P2 receptors.

Targeted deletion of ectonucleoside triphosphate diphosphohydrolase 1/CD39 leads to desensitization of pre- and postsynaptic purinergic P2 receptors. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

Targeted deletion of ectonucleoside triphosphate diphosphohydrolase 1/CD39 leads to desensitization of pre- and postsynaptic purinergic P2 receptors. Abstract Text:

Ulrich Schaefer,Takuji Machida,M Johan Broekman,Aaron J Marcus,Roberto Levi,

We previously reported that ATP coreleased with norepinephrine from cardiac sympathetic nerves activates presynaptic P2X purinoceptors (P2XR), thereby enhancing norepinephrine exocytosis. Blockade of ectonucleoside triphosphate diphosphohydrolase 1 (E-NTPDase1/CD39) potentiates norepinephrine exocytosis, whereas recombinant soluble CD39 (solCD39) in-hibits it. This suggested that CD39 gene (Entpd1) deletion would enhance purinergic and adrenergic signaling by preserving ATP and its norepinephrine-releasing activity. However, we found that the neurogenic contractile response of vasa deferentia from Entpd1-null (CD39(-/-)) mice was attenuated and accompanied by reduced activity of pre- and postsynaptic P2XR, whereas contractile responses to K(+) or norepinephrine remained intact. In addition, the magnitude of ATP and norepinephrine exocytosis from cardiac synaptosomes was decreased in CD39(-/-) mice. Inhibition of E-NTPDase1/CD39, or solCD39 administration, did not affect the attenuated contractile response of vasa deferentia from CD39(-/-) mice. Notably, Entpd1 deletion and pharmacological P2XR desensitization in control mice similarly attenuated vasa deferentia responses. Thus, excessive and prolonged ATP exposure resulting from CD39 deletion desensitizes pre- and postjunctional P2XR at the sympathetic neuromuscular junction. This diminishes purinergic activity directly and adrenergic activity indirectly. It remains to be determined whether this desensitization results from receptor internalization, changes in receptor conformation or phosphorylation. Shutdown of ATP signaling in CD39(-/-) mice may represent a defense mechanism for the prevention of purinergic overstimulation. Our findings emphasize the cardioprotective role of neuronal CD39: by reducing presynaptic facilitatory effects of neurotransmitter ATP, CD39 attenuates norepinephrine release and its dysfunctional consequences. Moreover, by virtue of its antithrombotic action CD39 can potentially prevent the transition from myocardial ischemia to infarction.

Targeted deletion of ectonucleoside triphosphate diphosphohydrolase 1/CD39 leads to desensitization of pre- and postsynaptic purinergic P2 receptors. Publishing Authors By Initials

U Schaefer,T Machida,MJ Broekman,AJ Marcus,R Levi,

For similar nervous system: synapses research abstracts see: nervous system: synapses research

PUBMED ID PMID:

MEDLINE DATE:

Targeted deletion of ectonucleoside triphosphate diphosphohydrolase 1/CD39 leads to desensitization of pre- and postsynaptic purinergic P2 receptors. Journal Published:

PUBLICATION TYPE: Research Support, U.S. Gov't,

Journal: The Journal of pharmacology and experimental thera

VOLUME: 322

Page Numbers: 1269-77

Journal Abbreviation: J. Pharmacol. Exp. Ther.

ISSN: 0022-3565

DAY: 12

MONTH: 06

YEAR: 2007

Targeted deletion of ectonucleoside triphosphate diphosphohydrolase 1/CD39 leads to desensitization of pre- and postsynaptic purinergic P2 receptors. Information

Number of References:

LANGUAGE: eng

NlmUniqueID: 376362

Targeted deletion of ectonucleoside triphosphate diphosphohydrolase 1/CD39 leads to desensitization of pre- and postsynaptic purinergic P2 receptors. Keywords Mesh Terms:

KEYWORDS: Synapses

MESH TERMS: chemistry

Chemical & Substance for Abstract: Targeted deletion of ectonucleoside triphosphate diphosphohydrolase 1/CD39 leads to desensitization of pre- and postsynaptic purinergic P2 receptors. Information

Substance Name: CD39 antigen

Registry Number: EC 3.6.1.5

Grant and Affiliation Information for Targeted deletion of ectonucleoside triphosphate diphosphohydrolase 1/CD39 leads to desensitization of pre- and postsynaptic purinergic P2 receptors.

AFFILIATION: Department of Pharmacology, Weill Cornell Medical College, 1300 York Ave., New York, NY, USA.

Country: United States

AGENCY: United States NHLBI

GRANT: R37 HL47073

ACRONYM: HL

MEDLINETA: J Pharmacol Exp Ther

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

Targeted deletion of ectonucleoside triphosphate diphosphohydrolase 1/CD39 leads to desensitization of pre- and postsynaptic purinergic P2 receptors Related Publications

• A new bioluminescent cellular assay to measure the transcriptional effects of chemicals that modulate the alpha-1 thyroid hormone receptor.
• Acute spinal cord injury.
• Attentional blinks as errors in temporal binding.
• Change in proptosis following extraocular muscle surgery: effects of muscle recession in thyroid-associated orbitopathy.
• Circadian regulation of cell cycle and apoptosis proteins in mouse bone marrow and tumor.
• Collinearity improves alignment in amblyopia as well as in normal vision.
• Determinants of long-term satisfaction after vertical banded gastroplasty.
• Effects of light and food schedules on liver and tumor molecular clocks in mice.
• Electronics for the pulsed rubidium clock: design and characterization.
• Evaluation of family drawings of physically and sexually abused children.
• Extended perceptual learning results in substantial recovery of positional acuity and visual acuity in juvenile amblyopia.
• Farnesoid X receptor modulates renal lipid metabolism, fibrosis, and diabetic nephropathy.
• Hemoperitoneum secondary to exogastric leiomyoblastoma of the stomach.
• Image segregation in strabismic amblyopia.
• Invasive procedures in the outpatient setting: managing the short-acting acenocoumarol and the long-acting phenprocoumon.
• Letter to the Editor concerning "Infrahyoid muscle flap for pharyngeal fistulae after cervical spine surgery: a novel approach-report of six cases" (by R.O. Seidl et al.).
• Modulation of sympathetic activity by tissue plasminogen activator is independent of plasminogen and urokinase.
• Multiple types of human papillomavirus in cervical samples in women in Campo Grande, MS, Brazil.
• Renin: at the heart of the mast cell.
• Sensitivity to biological motion drops by approximately 1/2 log-unit with inversion, and is unaffected by amblyopia.
• Targeted deletion of ectonucleoside triphosphate diphosphohydrolase 1/CD39 leads to desensitization of pre- and postsynaptic purinergic P2 receptors.
• Temporal dynamics of figure-ground segregation in human vision.
• The circadian timing system, a coordinator of life processes. implications for the rhythmic delivery of cancer therapeutics.
• Tissue factor-dependent blood coagulation is enhanced following delivery irrespective of the mode of delivery.
• Working life and mental health - A challenge to psychiatry?
• [Adrenal cortex function in pemphigus and pemphigoid forms studied by the determination of urinary elimination of reducing corticoids and 17-ketosteroids before and after ACTH; observations on the treatment of these dermatoses with cortisone and ACTH.]
• [Malaria and the work of two writer-physicians: Louis Ferdinand Celine and Carlo Levi.]
• [Report of a case of Queyrat's erythroplasia.]
• [Therapeutic efficacy of nitrogen mustard in a case of chronic lymphatic leukemia with diffuse cutaneous leukemia.]
• [Urinary elimination of 17-ketosteroids in some dermatoses.]